PLAC Test – The Test for Lp-PLA2 – Website

PLAC Test – The Test for Lp-PLA2 – Website
Focus on Prevention

The PLACTM test can help physicians identify patients at high risk for ischemic stroke or coronary heart disease. When used in conjunction with clinical evaluation and traditional risk assessment, the PLAC test can provide more accurate ischemic stroke and cardiac risk estimates to aid in determining the most appropriate treatment strategies to prevent stroke and heart disease.
The PLAC Test Advances Stroke and CHD Prevention

* The PLAC test is the only FDA-cleared blood test to aid in determining the risk for ischemic stroke associated with atherosclerosis
* Elevated Lp-PLA2 doubles an individual's risk of experiencing an ischemic stroke or coronary event, independent of traditional risk factors
* Lp-PLA2 is additive to blood pressure in predicting future incident ischemic stroke
* Major clinical studies have shown Lp-PLA2 to be highly predictive of cardiovascular risk
* The PLAC test provides accurate, reliable results that you can trust to identify your patients who may be at an elevated risk for a future ischemic stroke or coronary event

With a clear picture of your patient's cardiovascular risk, you can more accurately determine what type of goals and treatment programs your patient will need to minimize the risk of having a major cardiovascular event.